GU CANCERS SYMPOSIUM: Conference Highlights. 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY GENITOURINARY CANCERS SYMPOSIUM.

Authors :: DOBKOWSKI, DARLENE
ROSA, KRISTI
BRODERICK, JASON M.
Source :: Urology Times. Mar2024, Vol. 52 Issue 3, p22-23. 2p.
Publication Year :: 2024
Abstract: The article discusses highlights of the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium held in San Francisco, California. Topics included link of darolutamide to fewer hospitalizations in metastatic hormone-sensitive prostate cancer patients, cabozantinib and pembrolizumab therapy for urothelial carcinoma, and urinary minimal residual disease-negative status linked to recurrence-free outcomes with nadofaragene firadenovec in non-muscle-invasive bladder cancer.

Subjects :: *THERAPEUTIC use of antineoplastic agents
*ANTIANDROGENS
*COMBINATION drug therapy
*NON-muscle invasive bladder cancer
*HOSPITAL care
*CONFERENCES & conventions
*PROSTATE tumors
*TRANSITIONAL cell carcinoma
BLADDER tumors
GENITOURINARY organ tumors

Tools